Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1920-1925
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leor, J.
Right arrow Articles by Behar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leor, J.
Right arrow Articles by Behar, S.

Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors

A cohort study of 11,575 patients with coronary artery disease

Jonathan Leor, MD, FACC*, Henrietta Reicher-Reiss, MD, FACC{dagger}, Uri Goldbourt, PhD{dagger}, Valentina Boyko, MSc{dagger}, Shmuel Gottlieb, MD{dagger}, Alexander Battler, MD, FACC* and Solomon Behar, MD{dagger}

* Cardiology Department, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
{dagger} Neufeld Cardiac Research Institute, Tel Aviv University, Tel Hashomer, Israel



View larger version (11K):

[in a new window]
 
Figure 1 Actuarial survival for patients treated with angiotensin-converting enzyme inhibitors with and without aspirin.

 


View larger version (12K):

[in a new window]
 
Figure 2 Actuarial survival for patients with heart failure (New York Heart Association class ≥2) treated with angiotensin-converting enzyme inhibitors with and without aspirin.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement